ID: ALA3937630

Max Phase: Preclinical

Molecular Formula: C24H23N7OS

Molecular Weight: 457.56

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@H]1CN(c2scnc2-c2nc3ccccc3[nH]2)CCN1C(=O)Cn1ccc2cccnc21

Standard InChI:  InChI=1S/C24H23N7OS/c1-16-13-30(24-21(26-15-33-24)22-27-18-6-2-3-7-19(18)28-22)11-12-31(16)20(32)14-29-10-8-17-5-4-9-25-23(17)29/h2-10,15-16H,11-14H2,1H3,(H,27,28)/t16-/m0/s1

Standard InChI Key:  ZMFVJFWPPDAJQI-INIZCTEOSA-N

Associated Targets(Human)

C-X-C chemokine receptor type 3 2736 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

C-X-C chemokine receptor type 3 96 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 457.56Molecular Weight (Monoisotopic): 457.1685AlogP: 3.77#Rotatable Bonds: 4
Polar Surface Area: 82.94Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.21CX Basic pKa: 4.48CX LogP: 3.24CX LogD: 3.24
Aromatic Rings: 5Heavy Atoms: 33QED Weighted: 0.44Np Likeness Score: -1.46

References

1.  (2016)  4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives, 
2. Andrews SP, Cox RJ..  (2016)  Small Molecule CXCR3 Antagonists.,  59  (7): [PMID:26535614] [10.1021/acs.jmedchem.5b01337]